Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CC-4047 + Gemcitabine in Untreated Advanced Pancreatic Cancer
NCT00540579Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Nov 2007
- Primary completion
- Dec 2008
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in pancreatic cancer (PC), sponsored by SCRI Development Innovations. Started Nov 2007; status: completed.
02
Drugs
pomalidomide
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00540579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540579.